Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06828523 · ClinicalTrials.gov registry record · NA
Assessing Perceptual Effects of Interactive Tasks
A NA study of Amyotrophic Lateral Sclerosis, sponsored by Penn State University.
- Recruiting
- Registry status
- NA
- Development phase
- 1,300
- Enrollment target
- 1
- Study location
NCT06828523: Recruiting NA study of Amyotrophic Lateral Sclerosis, sponsored by Penn State University.
NCT06828523 is a NA study of Amyotrophic Lateral Sclerosis that is actively recruiting participants, run by Penn State University. The registered enrollment target is 1,300 participants, above the 885-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (47% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06828523, a NA study of Amyotrophic Lateral Sclerosis, is actively recruiting participants, sponsored by Penn State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,300 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, we will evaluate how solo, naive listeners perceive the speech of people with amyotrophic lateral sclerosis (ALS) and age-matched speakers produced across interactive and non-interactive contexts with an unfamiliar, naive interlocutor.
Primary Outcome
Perceptual judgments will be provided by solo, naïve listeners who did not participate in the interactions. Listeners will hear recorded speech of PALS and age-matched speakers recorded across the different tasks and indicate what they heard. The score will be expressed in percent. The possible range is between 0-100%. The higher scores mean a better outcome.
Conditions Studied
Interventions
- BEHAVIORAL Listener judgements of speech produced in different tasks
Study Locations (1)
Pennsylvania
- Speech Core, Pennsylvania State University - University Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,300 participants |
| Start Date | 2025-10-17 |
| Est. Completion | 2029-02-28 |
| Phase | NA |
What NCT06828523 shows while recruiting
NCT06828523 is an interventional study that assigns participants to a tested intervention. Its 1,300 participants enrollment target places it among the larger protocols in the corpus, above the 885-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (47% higher).
The record links to 1 condition, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Listener judgements of speech produced in different tasks is the first listed.
NCT06828523 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06828523 about?
NCT06828523 is a clinical study titled "Assessing Perceptual Effects of Interactive Tasks". In this study, we will evaluate how solo, naive listeners perceive the speech of people with amyotrophic lateral sclerosis (ALS) and age-matched speakers produced across interactive and non-interactive contexts with an unfamiliar, naive interlocutor.
What is the current status of trial NCT06828523?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,300 participants. The study started on 2025-10-17. Estimated completion is 2029-02-28.
What conditions does trial NCT06828523 study?
This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis.
What interventions are being tested in trial NCT06828523?
The interventions under investigation include: Listener judgements of speech produced in different tasks (BEHAVIORAL).
Who is sponsoring clinical trial NCT06828523?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06828523 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amyotrophic Lateral Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06828523's enrollment target sits among peer trials
1,300 10th of 102 higher than 93 of 102 other Amyotrophic Lateral Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amyotrophic Lateral Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Spinal Cord Associative Plasticity for ALS
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
Oral Intake of Enteral Nutrition Formula Preceding Placement and Feeding Via GTube and Its Impact on Formula Intolerance in pALS
RECRUITING · NA
-
Precise Robotically IMplanted Brain-Computer InterfacE
RECRUITING · NA
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04474223 · 1,300 participants · Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
- NCT04792684 · 1,300 participants
Collection of Samples USOPTIVAL Study
- NCT05166694 · 1,300 participants · NA
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
- NCT05282654 · 1,300 participants · NA
Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI